Want to join the conversation?
$BMY 2Q15 Q&A: Gilbert of Deutsche Bank asked about diversification. Giovanni answered that the period of next five years; growth will come disproportionately from Opdivo & Eliquis. Long term, thinking about a second cycle, early pipeline generating opportunities within IO, bringing six more assets in clinics and have early programs in other areas.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.